Suchergebnisse - "Laurie, Karen L"

PubPharm (7)

1

Which influenza viruses will emerge following the SARS-CoV-2 pandemic?

enthalten in: Influenza and other respiratory viruses | 2021

von Laurie, K. | Rockman, S.

2

New Technologies for Influenza Vaccines

enthalten in: Microorganisms | 2020

von Rockman, S. | Laurie, K. | Parkes, S. | +2

3

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages

enthalten in: The Journal of infectious diseases | 2018

von Laurie, K. | Horman, W. | Carolan, L. | +7

4

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages

Erschienen: 2018

von Laurie, K. | Horman, W. | Carolan, L. | +7

5

Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model

enthalten in: The Journal of infectious diseases | 2015

von Laurie, K. | Guarnaccia, T. | Carolan, L. | +10

CommentIn: J Infect Dis. 2015 Dec 1;212(11):1690-1. - PMID 25943204

6

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses

enthalten in: The Journal of infectious diseases | 2014

von Jegaskanda, S. | Vandenberg, K. | Laurie, K. | +6

CommentIn: EBioMedicine. 2017 May;19:10-11. - PMID 28431940

7

Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1

enthalten in: The Journal of infectious diseases | 2013

von Jegaskanda, S. | Laurie, K. | Amarasena, T. | +7

1
[1]